临床药师参与治疗1例药源性血小板减少症的药学监护

[1]	George J N, Raskob G E, Shah S R, et al. Drug-induced thrombocytopenia: a systematic review of published case reports[J]. Ann Int Med, 1998, 129: 886-890.
[2]	高桂卿,金叶,王建华,等. 妊娠合并血小板减少的病因、治疗方案及其分娩方式探讨[J]. 武警医学,2020,31(11):940-943.
[3]	Arnold D M, Kukaswadia S, Esmail A, et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia[J].J Thromb Haemost, 2013, 11(1):169-176.
[4]	Russell C D, Koch O, Laurenson I F, et al. Diagnosis and features of hospital-acquired pneumonia: a retro-spective cohort study[J]. Hosp Infect, 2016, 92(3): 273-279.
[5]	张传洲,陈杰,魏丽娜,等. 哌拉西林钠他唑巴坦钠致重度血小板减少1例[J]. 药品评价,2017,14(22):59-61.
[6]	卓实,单丽. 丙戊酸钠所致不良反应60例临床分析[J]. 临床合理用药,2016,9( 2A): 99-100.
[7]	张丽梅,付睿. 缺血性脑卒中使用脂肪乳后发生血小板减少的临床分析[J]. 中国新药与临床杂志,2014,6(33):468-471.
[8]	邢颖,杨媛,卞婧,等. 丙戊酸钠用于成年患者致血小板减少症的文献分析[J]. 中国药房,2015,26(3):336-338.
[9]	秦伟,王晓雪,杜雯雯,等. 药源性血小板减少症的研究进展[J]. 中国医院用药评价与分析,2017,17(5):577-580.
[10]	郑芸颖,崔向丽,刘丽宏. 药物引发血小板严重减少症1 例[J]. 临床药物治疗杂志,2017,15(3):64-66.